Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.
Curcio
Daniel
D
Fernández
Francisco
F
Jones
Ronald N
RN
Ferraro
Mary Jane
MJ
Reller
L Barth
LB
Schreckenberger
Paul C
PC
Sader
Helio S
HS
D000150:Acinetobacter / Q000145:classification / Q000187:drug effects*; D000151:Acinetobacter Infections / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods / Q000592:standards*; D008911:Minocycline / Q000031:analogs & derivatives* / Q000494:pharmacology; D000078304:Tigecycline
D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline